معرفی
Rafel Ramos Blanes is a Group Leader (R4) at the Institut d'Investigació Biomèdica de Girona (IDIBGI), focusing on vascular health research. He serves as principal investigator for European Commission-funded projects including the RBD Dimer recombinant protein vaccine against SARS-CoV-2 and obesity phenotype stratification studies.
His research spans cardiovascular health, metabolic disorders, immunology, and epidemiology. Key interests include vascular stiffness, cardiovascular risk assessment, metabolic phenotypes in diabetes, and immune responses to vaccines.
Dr. Ramos Blanes has published extensively on cardiovascular epidemiology, metabolic health, and immunology. His recent work demonstrates strong focus on: arterial stiffness and vascular events; SARS-CoV-2 vaccine immune responses; gut microbiome influences on cognition; and novel cardiovascular risk stratification methods.
